Clinical Trial Update: Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of the Listeria monocytogenes–based GVAX pancreas vaccine in patients with second-line or greater metastatic pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Listeria/GVAX Pancreas Vaccine (Listeria monocytogenes-based GVAX vaccine)

Snippet

Sponsor: Aduro Biotech, Inc. | Conditions: 2nd-line, 3rd-line and Greater Metastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-05-03